Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Canadian Non-Interventional Prospective Cohort Study on the Real - Life Assessment of Abilify Maintena ™ in Schizophrenia

NCT02131415 is registered in ClinicalTrials.gov with Lundbeck Canada Inc. as lead sponsor.

NCT NCT02131415
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02131415 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Canadian Non-Interventional Prospective Cohort Study on the Real - Life Assessment of Abilify Maintena ™ in Schizophrenia
Lead sponsor
Lundbeck Canada Inc.
Phase
Observational
Overall status
Terminated
Start date
May 31, 2014
Completion date
February 15, 2017
Enrollment
200 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia